CONFRONTO FRA IL VALORE CLINICO DEL TEST ECO-DIPIRIDAMOLO ED ECO-DOBUTAMINA

Translated title of the contribution: Comparison of clinical value of dipyridamole stress echocardiography and dobutamine stress echocardiography

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Dipyridamole and dobutamine stress echocardiography are gaining an increasing role in non invasive diagnosis and prognostic stratification of coronary artery disease. Both tests have shown a good sensitivity and an excellent specificity, greater than that of exercise test, in the diagnosis of coronary artery disease and they seem particularly useful in the subgroups of patients such as women, hypertensives and subjects with X syndrome, in whom exercise test has a low accuracy. In patients with recent infarction both dipyridamole and dobutamine echocardiography can identify patients with multivessel disease with greater accuracy than exercise test and can detect the site and extent of myocardial ischemia (homozonal vs heterozonal ischemia). Moreover, in patients with coronary artery disease dipyridamole echocardiography has shown a high prognostic value in predicting both death and major coronary events in the follow-up. Dobutamine and, to a lesser degree, dipyridamole echocardiography may play a significant role in the identification of viable myocardium and may therefore help in the selection of patients with depressed left ventricular function amenable to revascularization. Further studies are necessary to better delineate the usefulness and limitations of the two tests and to define the specific indications and contraindications of each test.

Original languageItalian
Pages (from-to)85-88
Number of pages4
JournalCardiovascular Imaging
Volume5
Issue number3
Publication statusPublished - 1993

Fingerprint

Stress Echocardiography
Dipyridamole
Exercise Test
Echocardiography
Coronary Artery Disease
Dobutamine
Left Ventricular Function
Infarction
Patient Selection
Myocardial Ischemia
Myocardium
Ischemia
Sensitivity and Specificity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

CONFRONTO FRA IL VALORE CLINICO DEL TEST ECO-DIPIRIDAMOLO ED ECO-DOBUTAMINA. / Previtali, M.

In: Cardiovascular Imaging, Vol. 5, No. 3, 1993, p. 85-88.

Research output: Contribution to journalArticle

@article{f9458e3271434199b9da2880a4627d83,
title = "CONFRONTO FRA IL VALORE CLINICO DEL TEST ECO-DIPIRIDAMOLO ED ECO-DOBUTAMINA",
abstract = "Dipyridamole and dobutamine stress echocardiography are gaining an increasing role in non invasive diagnosis and prognostic stratification of coronary artery disease. Both tests have shown a good sensitivity and an excellent specificity, greater than that of exercise test, in the diagnosis of coronary artery disease and they seem particularly useful in the subgroups of patients such as women, hypertensives and subjects with X syndrome, in whom exercise test has a low accuracy. In patients with recent infarction both dipyridamole and dobutamine echocardiography can identify patients with multivessel disease with greater accuracy than exercise test and can detect the site and extent of myocardial ischemia (homozonal vs heterozonal ischemia). Moreover, in patients with coronary artery disease dipyridamole echocardiography has shown a high prognostic value in predicting both death and major coronary events in the follow-up. Dobutamine and, to a lesser degree, dipyridamole echocardiography may play a significant role in the identification of viable myocardium and may therefore help in the selection of patients with depressed left ventricular function amenable to revascularization. Further studies are necessary to better delineate the usefulness and limitations of the two tests and to define the specific indications and contraindications of each test.",
author = "M. Previtali",
year = "1993",
language = "Italian",
volume = "5",
pages = "85--88",
journal = "Cardiovascular Imaging",
issn = "1120-0421",
publisher = "C E P I - Centro Editoriale Pubblicitario Italiano s.r.l.",
number = "3",

}

TY - JOUR

T1 - CONFRONTO FRA IL VALORE CLINICO DEL TEST ECO-DIPIRIDAMOLO ED ECO-DOBUTAMINA

AU - Previtali, M.

PY - 1993

Y1 - 1993

N2 - Dipyridamole and dobutamine stress echocardiography are gaining an increasing role in non invasive diagnosis and prognostic stratification of coronary artery disease. Both tests have shown a good sensitivity and an excellent specificity, greater than that of exercise test, in the diagnosis of coronary artery disease and they seem particularly useful in the subgroups of patients such as women, hypertensives and subjects with X syndrome, in whom exercise test has a low accuracy. In patients with recent infarction both dipyridamole and dobutamine echocardiography can identify patients with multivessel disease with greater accuracy than exercise test and can detect the site and extent of myocardial ischemia (homozonal vs heterozonal ischemia). Moreover, in patients with coronary artery disease dipyridamole echocardiography has shown a high prognostic value in predicting both death and major coronary events in the follow-up. Dobutamine and, to a lesser degree, dipyridamole echocardiography may play a significant role in the identification of viable myocardium and may therefore help in the selection of patients with depressed left ventricular function amenable to revascularization. Further studies are necessary to better delineate the usefulness and limitations of the two tests and to define the specific indications and contraindications of each test.

AB - Dipyridamole and dobutamine stress echocardiography are gaining an increasing role in non invasive diagnosis and prognostic stratification of coronary artery disease. Both tests have shown a good sensitivity and an excellent specificity, greater than that of exercise test, in the diagnosis of coronary artery disease and they seem particularly useful in the subgroups of patients such as women, hypertensives and subjects with X syndrome, in whom exercise test has a low accuracy. In patients with recent infarction both dipyridamole and dobutamine echocardiography can identify patients with multivessel disease with greater accuracy than exercise test and can detect the site and extent of myocardial ischemia (homozonal vs heterozonal ischemia). Moreover, in patients with coronary artery disease dipyridamole echocardiography has shown a high prognostic value in predicting both death and major coronary events in the follow-up. Dobutamine and, to a lesser degree, dipyridamole echocardiography may play a significant role in the identification of viable myocardium and may therefore help in the selection of patients with depressed left ventricular function amenable to revascularization. Further studies are necessary to better delineate the usefulness and limitations of the two tests and to define the specific indications and contraindications of each test.

UR - http://www.scopus.com/inward/record.url?scp=0027441861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027441861&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0027441861

VL - 5

SP - 85

EP - 88

JO - Cardiovascular Imaging

JF - Cardiovascular Imaging

SN - 1120-0421

IS - 3

ER -